{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:36:09Z","timestamp":1791941769538,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["J3492"],"award-info":[{"award-number":["J3492"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["SNF 31003A_138353"],"award-info":[{"award-number":["SNF 31003A_138353"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["31003A_163230"],"award-info":[{"award-number":["31003A_163230"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ijpddr.2016.07.003","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T12:41:17Z","timestamp":1469277677000},"page":"148-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target"],"prefix":"10.1016","volume":"6","author":[{"given":"David","family":"Leitsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2016.07.003_bib1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1051\/parasite\/2008153261","article-title":"Pathophysiology of enteric infections with Giardia duodenalis","volume":"15","author":"Buret","year":"2008","journal-title":"Parasite"},{"key":"10.1016\/j.ijpddr.2016.07.003_bib2","series-title":"Parasites\u2014Giardia","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"10.1016\/j.ijpddr.2016.07.003_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/nm.2758","article-title":"A\u00a0high-throughput drug screen for Entamoeba histolytica identifies a new lead and target","volume":"18","author":"Debnath","year":"2012","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijpddr.2016.07.003_bib5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s40475-015-0051-1","article-title":"Drug Resistance in the microaerophilic parasite Giardia lamblia","volume":"2015","author":"Leitsch","year":"2015","journal-title":"Curr. Trop. Med. Rep."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jac\/dkr192","article-title":"Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5- nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia","volume":"66","author":"Leitsch","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib7","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1371\/journal.pbio.0050211","article-title":"Nitroimidazole action in Entamoeba histolytica: a central role for thioredoxin reductase","volume":"5","author":"Leitsch","year":"2007","journal-title":"Plos. Biol."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2958.2009.06675.x","article-title":"Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance","volume":"72","author":"Leitsch","year":"2009","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpddr.2012.04.002","article-title":"Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia","volume":"2","author":"Leitsch","year":"2012","journal-title":"Intern. J. Parasitol. Drugs Drug Resis"},{"issue":"62","key":"10.1016\/j.ijpddr.2016.07.003_bib10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jac\/dkn142","article-title":"Identification of differentially expressed genes in a Giardia lamblia WB C6 clone resistant to nitazoxanide and metronidazole","volume":"2008","author":"M\u00fcller","year":"2008","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib11","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/AAC.01548-06","article-title":"A\u00a0novel Giardia lamblia nitroreductase, GlNR1, interacts with nitazoxanide and other thiazolides","volume":"51","author":"M\u00fcller","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib12","first-page":"165","article-title":"Mode of action of metronidazole on anaerobic bacteria and protozoa","volume":"93","author":"M\u00fcller","year":"1983","journal-title":"Surgery"},{"key":"10.1016\/j.ijpddr.2016.07.003_bib13","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/jac\/dkr029","article-title":"Nitroreductase (GlNR1) increasessusceptibility of Giardia lamblia and Escherichia coli to nitro drugs","volume":"66","author":"Nillius","year":"2011","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib14","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/00221287-148-8-2467","article-title":"Mechanisms of in\u00a0vitro development of resistance to metronidazole in Trichomonas vaginalis","volume":"48","author":"Rasoloson","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.ijpddr.2016.07.003_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1042\/BJ20121798","article-title":"Entamoeba histolytica: identification of thioredoxin- targeted proteins and analysis of serine acetyltransferase-1 as a prototype example","volume":"451","author":"Schlosser","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib16","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1242\/jcs.049411","article-title":"Neogenesis and maturation of transient Golgi-like cisternae in a simple eukaryote","volume":"122","author":"\u0160tefani\u0107","year":"2009","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib17","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1128\/AAC.01675-12","article-title":"Auranofin, a reprofiled drug, is effective against metronidazole-resistant Giardia lamblia","volume":"57","author":"Tejman-Yarden","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0166-6851(96)02661-8","article-title":"Characterisation and purification of pyruvate: ferredoxin oxidoreductase from Giardia duodenalis","volume":"79","author":"Townson","year":"1996","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.molbiopara.2015.01.005","article-title":"The effect of metronidazole on the cell cycle and DNA in metronidazole-susceptible and -resistant Giardia cell lines","volume":"198","author":"Uzlikova","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s11908-014-0396-y","article-title":"Treatment of giardiasis: current status and further directions","volume":"16","author":"Watkins","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"10.1016\/j.ijpddr.2016.07.003_bib22","unstructured":"World Health Organisation (WHO), model list of essential medicines, 19th list (April) 2015, http:\/\/www.who.int\/selection_medicines\/committees\/expert\/20\/EML_2015_FINAL_amended_AUG2015.pdf?ua=1, Last time accessed: June 27th, 2016."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320716300586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:47:11Z","timestamp":1761922031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320716300586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2211320716300586"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.07.003","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Giardia lamblia thioredoxin reductase as drug activating enzyme and as drug target","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2016.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}